RadNet

RadNet, Inc. provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. Its centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and reduce unnecessary invasive procedures. The firm offers magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures. RadNet was founded by Howard G. Berger in 1980 and is headquartered in Los Angeles, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

RadNet reports strong Q4 earnings, targets AI growth in 2023

RadNet's Q4 2022 performance demonstrated strong revenue and EBITDA growth, fueled by procedural demand and strategic investments in AI and expansion initiatives.
Despite challenges like labor market disruptions and a net loss, the company's focus on innovation, market positioning, and financial discipline bodes well for future profitability and growth.
Opportunities lie in AI revenue growth, de novo center profitability, and market expansion, positioning RadNet as a key player in the radiology industry with a clear path to sustained success.
With a commitment to quality services, shareholder value, and operational excellence, RadNet's strategic vision aligns with industry trends and growth opportunities, setting the stage for continued success and market leadership.

RadNet reports record Q1 revenue and EBITDA growth, eyes AI expansion

RadNet's Q1 2023 showcased strong financial performance and operational improvements. Despite challenges like net loss and labor inflation, the company is strategically positioned for growth through expansion and AI initiatives. Opportunities in advanced imaging services and cancer detection technologies present avenues for future success.

RadNet reports record Q2 earnings, eyes growth amid challenges

RadNet's Q2 2023 performance reflects strong revenue and EBITDA growth, driven by core Imaging Center segment.
While facing challenges like potential Medicare cuts and AI segment delays, the company is optimistic about growth opportunities.
Strategic initiatives in preventative medicine, AI, and outpatient services position RadNet for future success.
With a focus on innovation and financial strength, RadNet aims to capitalize on market shifts and technological advancements.

RadNet reports robust Q3 earnings, eyes growth through AI and partnerships

RadNet's Q3 performance reflects strong revenue growth and financial management, supported by AI division success and strategic initiatives for 2024.
Despite challenges such as staffing shortages and pricing discussions, the company's strengths in liquidity, debt management, and operational focus position it well for future growth.
Opportunities in acquisitions, AI investments, and partnerships offer avenues for expansion and innovation, driving RadNet's market leadership and service excellence.
Overall, RadNet's focus on growth, efficiency, and strategic partnerships underscores its commitment to sustainable success and market resilience in the healthcare industry.

RadNet reports record Q4 earnings, eyes AI growth opportunities

RadNet's Q4 2023 performance was strong, with record revenue and adjusted EBITDA driven by Imaging Center segment growth.
The company's focus on AI, acquisitions, and joint ventures presents growth opportunities but also challenges in reaching expansion targets.
Management's commitment to market leadership and financial strength positions RadNet well for future success and innovation.
RadNet's strategic investments and balance sheet strength support its growth initiatives and potential breakthroughs in AI solutions.

RadNet achieves record Q3 results, eyes AI growth opportunities

RadNet's Q3 2024 performance showcased exceptional financial results, underpinned by revenue growth, operational efficiency, and strategic guidance revisions for the full year.
The company's strengths lie in expansion initiatives, innovative collaborations, and a forward-looking approach towards technology commercialization and digital health advancement.
While facing challenges in regional adoption rates and program implementations, RadNet is well-positioned to capitalize on opportunities through strategic partnerships, AI profitability, and market expansion efforts.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

RadNet came in with another strong quarter in Q2 FY22, with operating metrics in-line with longer-term trends. Our findings indicate there's a number of inflection points within the investment debate that provide a solid bedrock looking ahead.

RadNet Presents With The Idiosyncratic Risk Premia To Deliver Risk-Adjusted Alpha

RadNet, Inc. (NASDAQ:RDNT ) Q2 2022 Earnings Conference Call August 9, 2022 10:30 AM ET Company Participants Mark Stolper - EVP and CFO Howard Berger - CEO Conference Call Participants Brian Tanquilut - Jefferies Sarah James - Barclays Mitra Ramgopal - Sidoti Operator Good day, ladies and gentlemen, and welcome to the RadNet, Inc. Second Quarter 2022 Financial Results Conference Call. Today's conference is being recorded.

RadNet, Inc. (RDNT) CEO Howard Berger on Q2 2022 Results - Earnings Call Transcript

RadNet (RDNT) delivered earnings and revenue surprises of 200% and 1.75%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

RadNet (RDNT) Tops Q2 Earnings and Revenue Estimates

LOS ANGELES, Aug. 09, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 353 owned and operated outpatient imaging centers, today reported financial results for its second quarter of 2022.

RadNet Reports Second Quarter Financial Results and Reaffirms 2022 Financial Guidance Ranges

Cloud-hosted platform delivers significant gains for California provider. GREENVILLE, S.C.

Open System Imaging Deploys eRAD RIS

LOS ANGELES, July 25, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its second quarter 2022 financial results on Tuesday, August 9th, 2022 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).

RadNet, Inc. Announces Date of its Second Quarter 2022 Financial Results Conference Call

DaVita

U.S. Physical Therapy

Despite the COVID-19 pandemic-induced challenges, rising dependence on telehealth and AI's dominant role are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, RDNT and USPH are well-poised to gain from the prospects.

3 Stocks to Watch From a Buoyant Outpatient Home Health Industry

LOS ANGELES, June 06, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Jefferies 2022 Global Healthcare Conference on Wednesday, June 8, 2022 at 9:00 a.m. Eastern Time.

RadNet, Inc. to Present at the Jefferies 2022 Global Healthcare Conference on June 8, 2022

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and LOS ANGELES , May 16, 2022 /PRNewswire/ -- RadNet, Inc., (NASDAQ: RDNT) today announced that it has received FDA clearances for its DeepHeatlh Saige-DX™ mammography and Quantib® Prostate 2.0 MRI artificial intelligence ("AI") algorithms.

RadNet Artificial Intelligence Subsidiaries, DeepHealth and Quantib, Obtain FDA Clearance for Mammography and Prostate AI Tools

RadNet, Inc. (NASDAQ:RDNT ) Q1 2022 Earnings Conference Call May 9, 2022 10:30 AM ET Company Participants Mark Stolper - Executive Vice President and Chief Financial Officer Howard Berger - Chief Executive Officer Conference Call Participants Brian Tanquilut - Jefferies Mitra Ramgopal - Sidoti Operator Good day and welcome to the RadNet, Inc. First Quarter 2022 Financial Results Conference Call. Today's conference is being recorded.

RadNet, Inc. (RDNT) CEO Howard Berger on Q1 2022 Results - Earnings Call Transcript

LOS ANGELES, May 09, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 351 owned and operated outpatient imaging centers, today reported financial results for its first quarter of 2022.

RadNet Reports First Quarter Financial Results with Record Revenue and Adjusted EBITDA(1) from Imaging Center Operations and Revises Upwards 2022 Financial Guidance Ranges

LOS ANGELES, May 06, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer will be presenting at the Bank of America Securities 2022 Health Care Conference in Las Vegas, NV on Wednesday, May 11, 2022 at 10:00 a.m. Pacific Time.

RadNet, Inc. to Present at the Bank of America Securities 2022 Healthcare Conference on May 11th, 2022

LOS ANGELES, April 27, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its first quarter 2022 financial results on Monday, May 9th, 2022 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).

RadNet, Inc. Announces the Date of its First Quarter 2022 Financial Results Conference Call

LOS ANGELES, March 22, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Sidoti & Company Spring 2022 Conference on Thursday, March 24th at 01:00 p.m. Eastern Time.

RadNet, Inc. to Present at the Sidoti & Company Spring 2022 Virtual Investor Conference on Thursday, March 24th

RadNet, Inc. (RDNT) CEO Howard Berger on Q4 2021 Results - Earnings Call Transcript

RadNet (RDNT) delivered earnings and revenue surprises of -31.58% and 4.26%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

RadNet (RDNT) Q4 Earnings and Revenues Miss Estimates

LOS ANGELES, March 01, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 347 owned and/or operated outpatient imaging centers, today reported financial results for its fourth quarter and full year ended December 31, 2021.

RadNet Reports Fourth Quarter 2021 Results and Releases 2022 Financial Guidance

LOS ANGELES, Feb. 23, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its fourth quarter 2021 financial results on Tuesday, March 1st, 2022 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).

RadNet, Inc. Announces Date of its Fourth Quarter 2021 Financial Results Conference Call

Despite the COVID-19 pandemic induced challenges, rising dependence on telehealth and AI's dominant role are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, RDNT and USPH are well-poised to gain from the prospects.

3 Stocks to Bank on the Buoyant Outpatient Home Health Industry

LOS ANGELES, Jan. 24, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 350 owned and operated outpatient imaging centers, today reported that it has acquired two unrelated Dutch technology companies, Aidence Holding B.V., (“Aidence”), a leading radiology artificial intelligence (“AI”) company focusing on clinical solutions for pulmonary nodule management and lung cancer screening and Quantib B.V., (“Quantib”), a leading radiology AI and machine learning company focusing on clinical solutions for prostate cancer and neurodegeneration.

RadNet Completes the acquisitions of Aidence Holding B.V. and Quantib B.V.

GREENVILLE, S.C., Nov. 29, 2021 /PRNewswire/ -- eRAD, a subsidiary of RadNet, Inc. (NASDAQ: RDNT), a leading provider of radiology image and data management software solutions, announced today that Advanced Imaging Concepts has deployed an array of eRAD solutions, including eRAD RIS, PACS, Speech Recognition, RADAR Communication Platform, and Physician Portal.

Advanced Imaging Concepts of Florida Deploys eRAD Radiology Business Solutions to Improve Efficiencies

LOS ANGELES, Nov. 15, 2021 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting virtually during a fireside chat at the Jefferies 2021 London Healthcare Conference being held November 16-19, 2021. The fireside chat will be available to registered participants on-demand beginning at 8:00 a.m. GMT (12AM Pacific Time) on November 18, 2021.

RadNet, Inc. to Present at the Jefferies London Healthcare Conference

RadNet, Inc. (RDNT) CEO Howard Berger on Q3 2021 Results - Earnings Call Transcript

RadNet (RDNT) delivered earnings and revenue surprises of 5.00% and -2.79%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

RadNet (RDNT) Q3 Earnings Top Estimates

RadNet Inc (NASDAQ: RDNT) reports Q3 revenue of $332.7 million, +14% Y/Y, missing the consensus of $340.68 million. Aggregate procedural volumes increased 15.6%; Same-center procedural volumes increased 10.0% Y/Y.

News for RadNet Stock (RDNT)